By Abbas Nazil
Dr. Fatima Suleiman Zuntu has been appointed as Director-General and Chief Executive Officer of the National Biosafety Management Agency (NBMA), marking a key leadership change in Nigeria’s biosafety regulatory sector.
The appointment made by President Bola Ahmed Tinubu takes effect from April 16, 2026, and is for an initial four-year term in line with the provisions of the National Biosafety Management Agency Act, 2015.
A statement from the Office of the Secretary to the Government of the Federation, Senator Georeg Akume, said Dr. Zuntu’s appointment reflects the administration’s intention to strengthen regulatory oversight in biotechnology and biosafety governance.
The statement, signed by the Head of Information and Public Relations, Chris Ugwuegbulam, described Dr. Zuntu as a seasoned public health professional and policy strategist with extensive experience in national programme implementation.
It added that she has a strong record of delivering impactful public sector initiatives, which is expected to support the agency’s mandate in regulating modern biotechnology safely in Nigeria.
President Tinubu, in the statement, urged the new DG/CEO to deploy her expertise in advancing the objectives of the agency and contributing to national development priorities.
The NBMA is the federal agency responsible for regulating the safe use of modern biotechnology, ensuring that genetically modified organisms and related technologies are properly assessed before use.
It also has the mandate of protecting human health and safeguarding the environment from any risks associated with biotechnology applications.
The government emphasized that effective leadership at the agency is critical at a time when biotechnology is increasingly influencing agriculture, health, and industrial development globally.
Dr. Zuntu’s appointment is expected to strengthen regulatory frameworks and improve Nigeria’s capacity to manage biosafety risks while encouraging safe scientific innovation.
Officials noted that her background in public health and policy development positions her to enhance coordination between scientific institutions, government agencies, and international partners.
The presidency also indicated that the new leadership will focus on improving compliance, strengthening institutional capacity, and ensuring better enforcement of biosafety regulations.
Although the announcement primarily focused on her professional credentials, it also reflects ongoing efforts by the Tinubu administration to reposition key regulatory agencies for improved performance.
Stakeholders in the biotechnology and environmental sectors are expected to watch closely how the new leadership approaches emerging challenges in genetically modified crops and related technologies.
The appointment comes at a time when Nigeria continues to expand its engagement with biotechnology innovations aimed at improving food security and healthcare outcomes.
Government officials believe that stronger oversight by NBMA will help balance innovation with safety, ensuring that scientific progress does not compromise environmental or public health standards.
Dr. Zuntu is expected to assume full responsibilities immediately, overseeing ongoing programmes and policy implementation within the agency.
Her leadership will also be assessed based on how effectively the agency responds to emerging biosafety concerns and global regulatory expectations in biotechnology governance.
